Ucello Therapeutics rallies $25m Series A

Ucello Therapeutics, a developer of CAR-T therapies, has closed $25 million in Series A financing.

11 February 2022•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles